Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

XPS Pensions expects to meet upgraded full-year expectations

(Sharecast News) - XPS Pensions told shareholders to expect another strong showing for the full-year, in line with previously upgraded expectations. The UK consulting and administration business specialising in the pensions sector said sales grew by 18% over the year ending on 31 March.

"As in previous years, ongoing regulatory change, new client wins, and the inflation-linkage of our contracts, combined with the resilience and predictability of our business model, has driven our robust financial performance," the company said.

Advisory sales were up by 10%, Administration revenues by 30% and SIP revenues by 15%, the company said in a post-close trading update.

XPS also announced the completion of its acquisition of Polaris Actuaries and Consultants Limited on 28 February.

Expectations were that the purchase would accelerate its strategy of becoming a leading player in the fragmented UK Insurance Consulting market.

The group was scheduled to hold a Capital Markets Event on 13 May.

As of 1427 GMT, shares of XPS Pensions were trading down by 4.33% to 375.50p, but remained within striking distance of their record highs.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.